Agios Pharmaceuticals (AGIO) Cash from Operations Growth (5y) (2017 - 2026)
Agios Pharmaceuticals (AGIO) Cash from Operations Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn |
| 10 | Agios Pharmaceuticals | 2.23 Bn | 1.49 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.68% |
| Dec 31, 2025 | -106.18% |
| Sep 30, 2025 | 3.47% |
| Jun 30, 2025 | -20.13% |
| Mar 31, 2025 | -1.14% |
| Dec 31, 2024 | -7.30% |
| Sep 30, 2024 | 0.32% |
| Jun 30, 2024 | 3.81% |
| Mar 31, 2024 | 0.67% |
| Dec 31, 2023 | 0.46% |
| Sep 30, 2023 | 0.70% |
| Jun 30, 2023 | 0.19% |
| Mar 31, 2023 | 0.78% |
| Dec 31, 2022 | 2.33% |
| Sep 30, 2022 | 1.69% |
| Jun 30, 2022 | -4.70% |
| Mar 31, 2022 | -5.70% |
| Dec 31, 2021 | -10.42% |
| Sep 30, 2021 | -27.31% |
| Jun 30, 2021 | -19.50% |